Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1988
A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066B V Clineschmidt, D J Pettibone, V J Lotti, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonistP K Siegl, R S Chang, N B Mantlo, et al.
Journal of Medicinal Chemistry|December 1, 1983
Pyridinylpiperazines, a new class of selective alpha 2-adrenoceptor antagonistsW S Saari, W Halczenko, S W King, et al.
The American Journal of Physiology|March 11, 1995
Discovery of L-162,313: a nonpeptide that mimics the biological actions of angiotensin IIS D Kivlighn, W R Huckle, G J Zingaro, et al.
European Journal of Pharmacology|December 29, 1995
In vitro pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptorsR S Chang, V J Lotti, T B Chen, et al.
Journal of Medicinal Chemistry|August 20, 1993
Triazolinones as nonpeptide angiotensin II antagonists. 1. Synthesis and evaluation of potent 2,4,5-trisubstituted triazolinonesL L Chang, W T Ashton, K L Flanagan, et al.
Science (New York, N.Y.)|October 11, 1985
A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceusR S Chang, V J Lotti, R L Monaghan, et al.
Journal of Medicinal Chemistry|March 5, 1993
Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazolesW T Ashton, C L Cantone, L L Chang, et al.
Journal of Medicinal Chemistry|September 15, 1995
Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.
Pageof 8